移植后癌症中的信号分子
Signaling Molecules in Posttransplantation Cancer.
作者信息
Balan Murugabaskar, Chakraborty Samik, Pal Soumitro
机构信息
Division of Nephrology, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA.
Division of Nephrology, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA.
出版信息
Clin Lab Med. 2019 Mar;39(1):171-183. doi: 10.1016/j.cll.2018.10.006. Epub 2018 Dec 18.
Abstract
Immunosuppression is essential to prevent graft rejection. However, immunosuppression impairs the ability of the host immune system to control viral infection and decreases tumor immunosurveillance. Therefore, immunosuppression after organ transplantation is a major risk factor for posttransplantation cancer. Notably, recent reports suggest that immunosuppressive agents can activate tumorigenic pathways independent of the involvement of the host immune system. In this review, we focus on cell-intrinsic tumorigenic pathways directly activated by immunosuppressive agents and discuss the much-described infection- and immune-mediated mechanisms of cancer development in organ transplant recipients.
摘要
免疫抑制对于预防移植物排斥至关重要。然而，免疫抑制会损害宿主免疫系统控制病毒感染的能力，并降低肿瘤免疫监视功能。因此，器官移植后的免疫抑制是移植后发生癌症的主要危险因素。值得注意的是，最近的报告表明，免疫抑制剂可独立于宿主免疫系统的参与而激活致瘤途径。在本综述中，我们重点关注由免疫抑制剂直接激活的细胞内在致瘤途径，并讨论器官移植受者中被广泛描述的感染和免疫介导的癌症发生机制。
相似文献
1
Signaling Molecules in Posttransplantation Cancer.移植后癌症中的信号分子
Clin Lab Med. 2019 Mar;39(1):171-183. doi: 10.1016/j.cll.2018.10.006. Epub 2018 Dec 18.
2
Graft rejection after immune checkpoint inhibitor therapy in solid organ transplant recipients.实体器官移植受者接受免疫检查点抑制剂治疗后的移植物排斥反应。
Acta Oncol. 2018 Oct;57(10):1414-1418. doi: 10.1080/0284186X.2018.1479069. Epub 2018 Jun 18.
3
Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the "Net State of Immunosuppression".免疫抑制剂与移植感染风险：管理“免疫抑制净状态”。
Clin Infect Dis. 2021 Oct 5;73(7):e1302-e1317. doi: 10.1093/cid/ciaa1189.
4
Human Papillomavirus-Related Malignancies in the Setting of Posttransplantation Immunosuppression.移植后免疫抑制背景下与人类乳头状瘤病毒相关的恶性肿瘤。
Arch Pathol Lab Med. 2018 Jun;142(6):711-714. doi: 10.5858/arpa.2017-0586-RA.
5
The historical link between solid-organ transplantation, immunosuppression, and skin cancer.实体器官移植、免疫抑制与皮肤癌之间的历史关联。
Dermatol Surg. 2004 Apr;30(4 Pt 2):595-7. doi: 10.1111/j.1524-4725.2004.30142.x.
6
Controlling the incidence of infection and malignancy by modifying immunosuppression.通过调整免疫抑制来控制感染和恶性肿瘤的发生率。
Transplantation. 2001 Dec 27;72(12 Suppl):S89-93.
7
[Cancer after transplantation].
Rev Prat. 1994 Feb 15;44(4):463-9.
8
Malignancy after Solid Organ Transplantation: Comprehensive Imaging Review.实体器官移植后的恶性肿瘤：全面影像学综述。
Radiographics. 2016 Sep-Oct;36(5):1390-407. doi: 10.1148/rg.2016150175.
9
[Pulmonary infections following solid organ transplantation].[实体器官移植后的肺部感染]
Orv Hetil. 2012 Jun 10;153(23):899-903. doi: 10.1556/OH.2012.29395.
10
Posttransplantation lymphoproliferative disorders.
Arch Intern Med. 2003 Sep 22;163(17):1997-2004. doi: 10.1001/archinte.163.17.1997.
引用本文的文献
1
Belatacept and non-melanoma skin cancer risk in kidney transplant recipients: a narrative review from a mechanistic and clinical perspective.贝拉西普与肾移植受者非黑色素瘤皮肤癌风险：基于机制和临床视角的叙述性综述
BMC Nephrol. 2025 Aug 23;26(1):487. doi: 10.1186/s12882-025-04373-z.
2
Reduced butyrate-producing bacteria and altered metabolic pathways in the gut microbiome of immunoglobulin A nephropathy patients.免疫球蛋白A肾病患者肠道微生物群中产生丁酸盐的细菌减少且代谢途径改变。
Sci Rep. 2025 Jul 31;15(1):28011. doi: 10.1038/s41598-025-13629-5.
3
Analyzing research trends in the relationship between immunosuppressants and cancer following organ transplantation: a bibliometric study from 2001 to 2023.分析器官移植后免疫抑制剂与癌症关系的研究趋势：一项2001年至2023年的文献计量学研究。
Discov Oncol. 2025 Mar 20;16(1):366. doi: 10.1007/s12672-025-02101-5.
4
A Combination therapy using an mTOR inhibitor and Honokiol effectively induces autophagy through the modulation of AXL and Rubicon in renal cancer cells and restricts renal tumor growth following organ transplantation.一种使用 mTOR 抑制剂和厚朴酚的联合治疗方法通过调节肾癌细胞中的 AXL 和 Rubicon 有效诱导自噬，并限制器官移植后肾肿瘤的生长。
Carcinogenesis. 2022 May 19;43(4):360-370. doi: 10.1093/carcin/bgab126.
5
A Novel Combination Treatment with Honokiol and Rapamycin Effectively Restricts c-Met-Induced Growth of Renal Cancer Cells, and also Inhibits the Expression of Tumor Cell PD-L1 Involved in Immune Escape.厚朴酚与雷帕霉素的新型联合治疗有效抑制c-Met诱导的肾癌细胞生长，并抑制参与免疫逃逸的肿瘤细胞PD-L1的表达。
Cancers (Basel). 2020 Jul 3;12(7):1782. doi: 10.3390/cancers12071782.
本文引用的文献
1
Risk factors associated with post-kidney transplant malignancies: an article from the Cancer-Kidney International Network.肾移植后恶性肿瘤相关危险因素：来自国际癌症-肾脏网络的一篇文章。
Clin Kidney J. 2018 Jun;11(3):315-329. doi: 10.1093/ckj/sfx122. Epub 2017 Oct 27.
2
Cancer in kidney transplant recipients.肾移植受者中的癌症。
Nat Rev Nephrol. 2018 Aug;14(8):508-520. doi: 10.1038/s41581-018-0022-6.
3
Belatacept in Solid Organ Transplant: Review of Current Literature Across Transplant Types.贝他西普在实体器官移植中的应用：移植类型的文献综述。
Transplantation. 2018 Sep;102(9):1440-1452. doi: 10.1097/TP.0000000000002291.
4
Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth.和厚朴酚抑制 c-Met-HO-1 肿瘤促进途径及其与钙调神经磷酸酶抑制剂介导的肾癌生长的相互作用。
Sci Rep. 2017 Jul 19;7(1):5900. doi: 10.1038/s41598-017-05455-1.
5
Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites.E6和E7癌蛋白在人乳头瘤病毒（HPV）引发的不同解剖部位恶性肿瘤中的功能作用
Cancers (Basel). 2016 Oct 19;8(10):95. doi: 10.3390/cancers8100095.
6
Cyclosporine A Inhibits the T-bet-Dependent Antitumor Response of CD8(+) T Cells.环孢素A抑制CD8(+) T细胞依赖T-bet的抗肿瘤反应。
Am J Transplant. 2016 Apr;16(4):1139-47. doi: 10.1111/ajt.13597. Epub 2016 Feb 8.
7
Does the nature of residual immune function explain the differential risk of non-melanoma skin cancer development in immunosuppressed organ transplant recipients?残余免疫功能的本质是否能解释免疫抑制器官移植受者发生非黑色素瘤皮肤癌的不同风险？
Int J Cancer. 2016 Jan 15;138(2):281-92. doi: 10.1002/ijc.29450. Epub 2015 Feb 5.
8
The role of hypoxia-inducible factors in organ donation and transplantation: the current perspective and future opportunities.缺氧诱导因子在器官捐献和移植中的作用：当前的观点和未来的机遇。
Am J Transplant. 2014 Jul;14(7):1481-7. doi: 10.1111/ajt.12737. Epub 2014 Jun 6.
9
Novel approaches to preventing ischemia-reperfusion injury during liver transplantation.肝移植期间预防缺血再灌注损伤的新方法。
Transplant Proc. 2013 Jul-Aug;45(6):2083-92. doi: 10.1016/j.transproceed.2013.04.004.
10
Cumulative incidence of cancer after solid organ transplantation.实体器官移植后的癌症累积发生率。
Cancer. 2013 Jun 15;119(12):2300-8. doi: 10.1002/cncr.28043. Epub 2013 Apr 4.
Zotero 插件